Figure 2.
SpCas9 stimulates immune response in C57BL/6J immunocompetent mice. (a) Growth curves depicting average tumor volumes (±SD) of mT3-2D (n = 10) and mT3-2D-ELC4 (n = 10) grown in immunocompetent WT mice. (b) Detection of anti-SpCas9 IgG1 levels in serum of immunocompetent mice.